Unlearn is a pioneering technology company based in San Francisco, founded in 2017 by a team of world-class machine learning scientists. The company is dedicated to advancing artificial intelligence (AI) to eliminate trial and error in medicine, particularly in the realm of clinical trials. By innovating advanced machine learning methods and leveraging generative AI, Unlearn creates AI-generated digital twins of individual trial participants, enabling smaller and more efficient clinical trials that expedite the delivery of effective medicines to patients. With a strong belief that AI will define the future of medicine, Unlearn is committed to inventing new technologies rather than relying on existing ones. The company fosters a culture of ambition, discipline, grit, receptiveness to new ideas, storytelling, and teamwork, and has successfully raised significant venture capital to support its mission.